The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization

Journal of Nuclear Medicine

Volumn 55, Issue 9, 2014, Pages 1452-1458

  Tapp, Katie N ^a,b   Lea, William B ^a   Johnson, Matthew S ^a   Tann, Mark ^a   Fletcher, James W ^a   Hutchins, Gary D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

90Y dosimetry; Quantitative PET CT; Reconstruction bias

Indexed keywords

FLUORINE 18; YTTRIUM 90; DIAGNOSTIC AGENT; YTTRIUM;

ACCURACY; ARTICLE; ARTIFICIAL EMBOLISM; BREMS RADIATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONCENTRATION (PARAMETERS); DOSIMETRY; HEPATIC ARTERY RADIOEMBOLIZATION; HUMAN; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LIVER PARENCHYMA; LIVER TUMOR; MAJOR CLINICAL STUDY; PET-CT SCANNER; QUANTITATIVE ANALYSIS; RADIOISOTOPE DISTRIBUTION; RADIOLOGY PHANTOM; RETROSPECTIVE STUDY; SIGNAL NOISE RATIO; 90Y DOSIMETRY; COMPUTER ASSISTED TOMOGRAPHY; IMAGE PROCESSING; IMAGE QUALITY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE PET/CT; RADIOMETRY; RECONSTRUCTION BIAS;

90Y DOSIMETRY; QUANTITATIVE PET/CT; RECONSTRUCTION BIAS;

EMBOLIZATION, THERAPEUTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 84907009524     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.113.133629     Document Type: Article

References (25)

1. Lewandowski RJ, Sato KT, Atassi B, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571-592.
2. Dancey JE, Sphepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41:1673-1681.
3. Sarfaraz M, Kennedy AS, Coa ZJ, et al. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys. 2003;30:199-203.
4. Salem R, Thurston KG. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251-1278.
5. Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47:1209-1211.
6. Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med. 2011;52:72-76.
7. Lhommel R, Goffette P, Van den Eynde M, et al. Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging. 2009;36:1696.
8. Willowson K, Forwood N, Jakoby BW, Smith AM, Bailey DL. Quantitative 90Y image reconstruction in PET. Med Phys. 2012;39:7153-7159.
9. Kao YH, Tan EH, Ng CE, Goh SW. Yttrium-90 time-of-flight PET/CT is superior to bremsstrahlung SPECT/CT for postradioembolization imaging of microsphere biodistribution. Clin Nucl Med. 2011;36:e186-e187.
10. Bagni O, D'Arienzo M, Chiaramida P, et al. 90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy. Nucl Med Commun. 2012;33:198-204.
11. Carlier T, Eugène T, Bodet-Milin CB, et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013;3:11.
12. Lhommel R, van Elmbt L, Goffette P, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging. 2010;37:1654-1662.
13. D'Arienzo M, Chiaramida P, Chiacchiararelli L, et al. 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun. 2012;33: 633-640.
14. Selwyn RG, Nickles BR, Thomadsen BR, DeWerd LA, Micka JA. A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot. 2007;65:318-327.
15. Ahn S, Fessler JA. Emission image reconstruction for randoms-precorrected PET allowing negative sinogram values. IEEE Trans Med Imaging. 2004;23: 591-601.
16. Rahmim A, Cheng JC, Blinder S, Camborde ML, Sossi V. Statistical dynamic image reconstruction in state-of-the-art high resolution PET. Phys Med Biol. 2005;50:4887-4912.
17. Li Q, Leahy RM. Statistical modeling and reconstruction of randoms precorrected PET data. IEEE Trans Med Imaging. 2006;25:1565-1572.
18. Casey ME. Point Spread Function Reconstruction in PET. Malvern, PA: Siemens Medical Solutions; 2007.
19. Casey ME, Hoffman EJ. Quantitation in positron emission computed tomography: 7 - a technique to reduce noise in accidental coincidence measurements and coincidence efficiency calibration. J Comput Assist Tomogr. 1986; 10:845-850.
20. Brasse D, Kinahan PE, Lartizien C, et al. Correction methods for random coincidences in fully 3D whole-body PET: impact on data and image quality. J Nucl Med. 2005;46:859-867.
21. Bao Q, Chatziioannou AF. Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method. Med Phys. 2010; 37:6070-6083.
22. Stute S, Carlier T, Cristina K, et al. Monte Carlo simulations of clinical PET and SPECT scans: impact of the input data on the simulated images. Phys Med Biol. 2011;56:6441-6457.
23. Bolch WE, Bouchet LG, Robertson JS, et al.; Medical Internal Radiation Dose Committee. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level. J Nucl Med. 1999;40(suppl): 11S-36S.
24. Dieudonné A, Hobbs RF, Bolch WE, Sgouros G, Gardin I. Fine-resolution voxel S values for constructing absorbed dose distributions at variable voxel size. J Nucl Med. 2010;51:1600-1607.
25. Package insert: TheraSphere® yttrium-90 glass microspheres. TheraSphere website. http://www.therasphere.com/physicians-package-insert/package-insert-us.pdf. Accessed June 17, 2014.